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Senior Thesis
Abstract

Systemic Lupus Erythematosus (SLE) is a chronic , incurable, autoimmune disease
that affects as many as two million persons in the United States . Current nutritional
guidelines are very basic and revolve around specifics of the treatment of symptoms as
seen with drug-nutrient interactions . Although current opinion does not directly see the
onset of this disease linked to dietary factors, recent research may indicate that there is a
link to a possible deficienc y of pantothenic acid . This is not a widely accepted theory ,
but has some very unique observations which shed a new and interesting light on possible
interventions through nutrition .

Introduction

Systemic lupus erythematosus (SLE) affects more people than AIDS , cerebral
palsy, multiple sclerosi s, sickle-cell anemia , and cystic fibrosis combined , affecting
between 1,400 ,000 and 2,000,000 people (1 ). Economically , it is a major health concern
costing annuall y as much as $6,000 - 10,000 or more for an individual (much of which
comes out of Medicaid and Medicare funds) and 67% of patients reporting a "complete or
partial loss of their income because they are unable to work " (2). Seventy percent of
persons diagnosed with lupus are diagnosed with the systemic form , and 50% of these
people will have impairment of a major organ secondary to the disease. As lupus
progresses in the individual quality oflife also decreases markedly. Sixty-five percent of
people with lupus cite pain as the most difficult area to cope with regarding their lupus
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(2). Thus it can be seen that there is a great public concern with regard to lupus as it not
only has a significant economic impact but is also important in improving millions of
people ' s quality-of-life.

Although there is much research on this prolific disease, and

there continues to be a seemingly exponential amount published every year , there is still
no cure and much remains unknown.

Basics of Systemic Lupus Erythematosus
SLE is a chronic inflammatory autoimmune disease that affects many of the body
systems including the muscles , bones , skin, kidneys , nerves, brain , blood , heart and lungs
( 1, 4, 5). It is primarily seen in women of child-bearing age and is most prevalent among
African-Americans , Asians , and Hispanic-Americans (3, 5). As is seen with autoimmune
diseases , the normal immun e cells becom e hyperactive. Antibodies are produced which
attack normal "self ' cells that would typically be ignored (3). This can happen in two
ways. First , there may be an actual change in the body tissue making it unrecognizable to
the immune cells. Or secondly there may be "faulty lymphocytes " (sensitive to "self '
cells) which become unregulated because of a disruption in the homeostatic processes
that would normally eliminate these faulty cells (6). Why this happens is not certain , but
many researchers speculate it may stem from genetic susceptibility combined with
triggering environmental factors such as "infections , antibiotics (especially those in the
sulfa and penicillin groups) , ultraviolet light, extreme stress, certain drugs, and
hormones" (7). The seriousness of the disease is individual and can range from mild to
fatal, though most patients experience only mild symptoms (1).
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Patients with lupus may experience arthritis, pyrexia, malaise, butterfly-rash on
cheeks , hepatosplenomegaly,

weight loss , diarrhea, pleurisy, pericarditis , and renal

damage (1 ). In mild to moderate cases of lupus these symptoms are not consistent but
cycle between flare-ups and resolution .

Pharmaceutical Treatment
Lupus is not a curable disease and manifests itself uniquely in each person.
Individual symptoms are medically treated with many different types of drugs which
must be constantly reevaluated as patient needs may change following a "flare-up " .
Common drugs include steroids , particularly corticosteroids, and antimalarials , to name a
very few (4, 5). Knowledge of these drugs is important to the nutritional professional
because of the drug s' effect on nutrient metabolism , needs , and excretion (8).
Corti costeroid s are used becaus e of their anti-inflammator y and
immunoregulator y properti es (7). Usage alters protein , sodium , fluid , and calcium needs
(8) . Weight gain is also a common side effect with the appetite stimulating -affect of this
drug (2). Because of the hormone-like actions of these drugs they must be carefully dosed
and side effect s should be closel y monitored. Of particular concern with the largely
predominant SLE female population is the occurrence of osteoporosis associated with use
of those drugs. Calcium and vitamin D supplementation are usually indicated to prevent
the characteristic bone wasting seen with long-term use of the drug (4 ).
Antimalarials , known as hydroxychloroquine or more specifically Plaquenil®, are
used in cases of mild to moderate lupus to treat skin and joint symptoms (4, 7, 9). They
are the very commonly used in treatment of SLE symptoms because they do not have the
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undesirable side-effects of corticosteroids or the risk of immunosuppressors (4). They
are not particularly nutritionally related, but do cause symptoms that affect adequate oral
intake . Side effects may include nausea , abdominal cramping, and diarrhea (8). It can
take a term of several months before these drugs begin to show signs of working (7).

Recent Research
Unlike many chronic diseases such as cancer, heart disease, and stroke, dietary
guidelines for lupus are vague . No current research has revealed a definite link between
diet and lupus . This is, however , an emerging, dynamic area of research . Scientists are
delving into possible treatments of lupus-related complications, as well as nutrient
metabolism and biochemical pathways , in hopes of gaining a clue as to the etiology,
management , and possible cure of this disease , or at least insight into better management.
Research involving nutrition and lupus usually centers around medication side-effects ,
antioxidants and anti-inflammatory compounds , or lipid-lowering diet modifications (4,
10).
Research with anti-inflammatory nutrients has revolved around fish-oil
supplementation. A small study cited by Dr. Schur in his overview of lupus found
improvement in lupus symptoms (4 ). Other studies cited by E. Goh et al in their review of
alternative lupus therapies , found improvement in the milder lupus symptoms such as
active rash and joint pain ( 10). Animal studies also cited by Goh found that fish oil
supplementation may have a renal protective effect as well (10). However, almost all
trials conducted were small trials with potential for treatment but definitely needing more
research for conclusive recommendations.
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Cardiovascular disease risk factors occur in 53% of lupus patients and contribute
significantly to mortality among SLE patients (11). In developed countries, premature
atherosclerosis is the main cause of death among those with SLE (5), Thus research
regarding cardiovascular disease and diet specifically among those affected with lupus is
rational and necessary. Schur cites multiple studies involved with SLE and
hyperlipidemia, emphasizing the need for a heart-healthy diet among SLE patients, more
especially because of the prevalent use of corticosteroids (4 ). One additional study of
note focused on treatment of lupus complications and the effect of a cholesterol-lowering
diet (8). Patients with SLE in this study were found to have a significant and sustained
improved quality of life after twelve weeks on a cholesterol-lowering diet. It was
ascertained that this may not have been entirely due to the diet, but also to the intensive
counseling and weight loss (8) .
With much of lupus pathogenesis still a mystery it is rational to surmise upon the
possibility of a more direct nutritional component than what has been previously
discussed. Although there is minimal research in this area one recent theory, of particular
nutrition interest , proposed by Dr. LH Leung, is that of lupus being a "combined
deficiency disease " with particular emphasis on this deficiency being one of pantothenic
acid (12) . Because this theory is very new and extremely nutritionally pertinent, showing
potential for lupus treatment via nutrition therapy, it will be summarized and discussed in
some detail.
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Lupus and Pantothenic Acid
Pantothenic acid and the acetylation process involving Co A is the basis of Dr.
Leung' s theory for treatment of lupus. A review of its components is important to further
understand where Dr. Leung is coming from.
Pantothenic acid is one of the B-vitamins and is also known as B5. Its main
function is as an inseparable element of coenzyme A (Co A) . Co A is essential in the
body for numerous functions such as synthesis of the acetylcholine neurotransmitter, the
melatonin hormone, essential fats, cholesterol, and steroid hormones (13). It is also
involved in heme synthesis and metabolism of several drugs in the liver and kidneys (13,
14). Because of minimal research , only adequate intakes (AI) are defined for the general
populations ; for adults this AI is 5 mg/day (14). It is estimated that the average American
consumes about 5-6 mg/day of pantothenic acid , thus supposedly meeting needs ( 14).
Pantothenic acid is fairly ubiquitous in the food supply and so deficiencies are not readily
noticeable or even thought to exist (14). Pantothenic acid deficiencies , however, have
been clinically induced(l 3). Symptoms such as fatigue and headache were seen, those
these resolved with supplementation (13) .
The acetylation process is a cycle involving the transfer of an acetyl group to a
molecule ready to be metabolized. When Co A is in the acetylation process in a thiol
form which interacts with pyruvate and is restored to its original Acetyl-Co A form (14) .
This cycle is thought to not be perishable, but it is reasonable to accept that a deficiency
would strain this cycle and cause a "rationing" of available substance to most important
organ systems, an idea that will be further expounded on later with specific implications
with lupus.
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Dr. Leung's theory proposes that people affected with lupus are deficient in
coenzyme A (Co A), a derivative of pantothenic acid, as noted above (12). Basing the
theory on recent research which "suggests the low activity of an enzyme can be remedied
by raising the concentration of cellular coenzyme levels by administering high does of
the corresponding vitamin ," Dr. Leung proposes that the possible lupus-related
pantothenic acid deficiency may not be more from an increased demand because of
specific gene mutations , rather than from an insufficient intake (9). This rationale is
easily accepted with the influx of nutrient-gene interactions being identified and the
popular theory that an individual's nutrient needs are very specific based on their genetic
make-up .
Dr. Leung's basic rationale in linking a pantothenic acid deficiency and lupus
derives from his study of drug-induced lupus erythematosus (DILE). According to Dr.
Leung, there are about 70 or so drugs, all very different, which cause DILE . Once
administration of these drugs stops, the symptoms and complications of DILE resolve.
Since these drugs all have different properties, metabolic by-products, and elimination
fates, Leung hypothesizes that the only commonality among these drugs is "from the
point they enter the body to the time they are eliminated." By examining three drugs,
which most commonly cause DILE, Dr. Leung was able to identify the marked and
unique similarity in the metabolism process of these drugs. Thus, Leung hypothesized
that DILE drugs ' effect was not directly related to the drug's properties, but rather
through the the process by which they are metabolized, namely the acetylation process.
This means, in a nutshell, that the acetylation process is being disrupted or strained,
causing lupus complications (9).
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Leung supports his theory by showing how different complications of SLE are
linked with the acetylation pathway and a genetic inclination. For example, the high rate
of occurrence of SLE in women is because as women hit puberty and hormones are
stimulated, there is an increased , heavy demand for Co A, which is vital as a precursor to
cholesterol and hormone synthesis. As this occurs , lupus begins to manifest itself. This is
consistent with current findings that show lupus predominates in women of childbearing
age. Furthermore , studies unrelated to lupus have shown a possible increased need for
pantothenic acid with use of oral contraceptives and the influx of estrogen and
progesterone (14).
Further evidence for Leung's theory lies in the appearance of lupus symptoms
following a classic deficiency timeline, meaning that less immediately vital body
systems , such as the skin , are affected first with progression to an end-stage multi-organ
failure state. This type of deficiency progre ssion is seen with other vitamins such as
vitami n C and scurvy (skin conditions progress to multiple organ failure) (15). The
appearance of lupus symptoms is congruous to what could be expected with a deficiency
in that they appear gradually. This could very easily be related to the slow build-up of a
deficiency over time as the body taxes its stores.
Finally, and most importantly , Leung wisely points out, "it can hardly be
expected that patients , in having a deficiency in one dietary element, either due to an
elevated demand or an actual deficient intake , should have his deficiency limited to that
particular element. " This would then explain the wide-variation among individuals and
the experienced symptoms, as seen in lupus, making SLE a "disease that arises from
combined dietary factor deficiencies the main deficiency of which is pantothenic acid."
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Dr. Leung's recommendation, based on this theory is that ten grams of pantothenic acid
per day may be an "appropriate replacement" in SLE (12). This is in accordance with the
recommendations made by The Food and Nutrition Board of the Institute of Medicine
which sees tolerance in levels of up to 1200 mg, though the recommendation is 5 mg/day
for adults (based on extremely limited research) (14). This new theory has only been
substantiated by one small, yet successful trial; however it draws out some important
points regarding a possible treatment of lupus through nutritional intervention ( 12).

VI. Current Nutritional Recommendations
Despite lack of specific concrete recommendations for diet in regards to lupus, the
importance of maintaining a good nutrition status is recognized .
The Lupus Foundation of America states,

"Although much is still not known about the nutritional
factors in many kinds of disease, no one questions the
necessity of a well-balanced diet. Fad diets, advocating
an excess or an exclusion of certain types of foods , are
much more likely to be detrimental than beneficial in
any disease, including lupus. Scientists have shown that
both antibodies and other cells of the immune system
may be adversely affected by nutritional deficiencies or
imbalances.

Thus, significant

deviations from

a

balanced diet may have profound effects on a network
as complex as the immune system" (7).
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It is recommended , then , that the nutritional management of lupus
patients be very individualized and focused on the degree of an
individual's lupus as well as the mode of treatment (8).

Role of the Nutrition Professional
It may seem that the nutrition professional has an insignificant role in lupus

without specific dietary guidelines set for this disease. On the contrary, however, the
nutrition professional has a large role in improving quality of life through helping with
the treatment of common side-effects of pharmaceutical agents and chronic disease in
general. Many of these conditions have been previously mentioned.
Many nutritional professionals in the renal and diabetes arena will be in
contact with patients with lupus. Steroid-induced diabetes may occur with the long-term
use of corticosteroids. Diabetic treatment for patients with lupus does not differ from that
of patients without lupus . However, with the variance of individual lupus symptoms and
unpredictability of "flare-up " catalysts, medications should be closely monitored for
tolerance (16). Furthermore, with the increased risk for infection among lupus patients ,
maintenance of normal blood-sugar levels is of increased importance (4).
Renal dietitians will also have contact with patients with lupus as kidney failure is
a common complication from lupus. As with diabetes , treatment does not differ from that
of the typical patient dealing with renal disease. However, careful control of diet may be
of increased importance to prevent flare-ups ( 16).
Nutrition professionals should be knowledgable of side-effects of pharmaceutical
treatment for lupus and the individual nutritional implications of each of these often long-
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term usage drugs. Dietitians can help through weight management, treatment and
monitoring of osteoporosis , and advice with regards to gastrointestinal intolerances and
appetite changes (16) . The importance of staying abreast of this current burgeoning area
of research is paramount for effective patient treatment.

Conclusion
Lupus is a serious , prolific disease among the American population and around
the world. As this area ofresearch evolves through nutritional and genetic studies, there
is a bright prospect for a more definitive treatment and possible cure to emerge.
Pantothenic acid may play a role in treatment of lupus, but more studies are needed to
define this pathway and establish conclusive evidence. Recent research does seem to
indicate , however , that the proposed doses are within a non-toxic range and do appear to
provide some benefit. As more research is being done, the nutritional management of
lupus patients should be evaluated and monitored by skilled professionals to assure the
best outcome possible .
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